News
Updated efficacy results of olverembatinib (HQP1351) in patients with tyrosine kinase inhibitor (TKI)-resistant succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback